Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Bausch Health (NYSE:BHC) announced that CEO Thomas J. Appio will participate at the 44th Annual J.P.

Rhea-AI Summary

Bausch Health (NYSE:BHC) announced that CEO Thomas J. Appio will participate at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 14, 2026. Executive attendees include EVP/CFO Jean-Jacques Charhon and EVP/CMO & Head of R&D Jonathan Sadeh, M.D..

A live audio webcast will be accessible via the company's Investor Relations website at http://ir.bauschhealth.com/events-and-presentations, with a replay available after the event. Time: 3:45 p.m. PT / 6:45 p.m. ET.

Argus Jan 5 session

+2.64% close to close Open Argus

Details

News Market Reaction – BHC

On Jan 5, the day this news came out, BHC closed 2.64% above the previous close.

Data tracked by StockTitan Argus for the Jan 5 session.

Market Context

This announcement highlights Bausch Health’s participation in the 44th Annual J.P. Morgan Healthcare...

Analysis

This announcement highlights Bausch Health’s participation in the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, with senior leadership engaging investors via a webcast. It follows a series of balance-sheet-focused actions and a strategic acquisition in China, as seen in recent months’ news and 8-K filings. Investors may watch for any incremental commentary on debt structure, the Bausch + Lomb stake, or international growth to contextualize this ongoing investor-relations outreach.

Key Figures

Conference edition: 44th Annual Conference date: January 14, 2026 Session time PT: 3:45 p.m. U.S. PT +1 more

Conference edition

44th Annual

J.P. Morgan Healthcare Conference

Conference date

January 14, 2026

Bausch Health participation date at JPM Healthcare

Session time PT

3:45 p.m. U.S. PT

Scheduled presentation time at conference

Session time ET

6:45 p.m. U.S. ET

Corresponding Eastern Time for presentation

Historical Context

5 past events · Latest: Dec 23

5 events

1. Dec 23

   Debt exchange results

   24h Move

   -1.9%

   Final results and expiration of senior secured notes exchange offers.

2. Dec 08

   Early exchange results

   24h Move

   -0.3%

   Early participation results for exchange into new 2032 senior notes.

3. Dec 01

   China acquisition

   24h Move

   +11.0%

   Solta Medical acquisition of longtime China distributor to deepen local presence.

4. Nov 24

   Launch exchange offers

   24h Move

   +1.3%

   Launch of offers to exchange 2028 notes for new 2032 senior secured notes.

5. Nov 18

   Conference participation

   24h Move

   +0.8%

   Participation in Evercore healthcare conference with webcast for investors.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LAVAL, QC, Jan. 5, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Thomas J. Appio, Chief Executive Officer, will participate at the 44^th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 14, 2026. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.

Jean-Jacques (JJ) Charhon, EVP, Chief Financial Officer, and Jonathan Sadeh, M.D., EVP, Chief Medical Officer and Head of R&D will also be in attendance.

Details

Date: Wednesday, January 14, 2026

Time: 3:45 p.m. U.S. PT / 6:45 p.m. U.S. ET

Webcast: http://ir.bauschhealth.com/events-and-presentations

A replay of the event will be available on the investor relations website following the event.

About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.

Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995.  Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference.  Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor Contact:	Media Contact:
Garen Sarafian	Katie Savastano
ir@bauschhealth.com	corporate.communications@bauschhealth.com
(877) 281-6642 (toll free)	(908) 569-3692

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference-302651870.html

SOURCE Bausch Health Companies Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Bausch Health (BHC) present at the J.P. Morgan Healthcare Conference in 2026?

Bausch Health will present on January 14, 2026 at 3:45 p.m. PT / 6:45 p.m. ET.

Who from Bausch Health (BHC) will attend the January 14, 2026 J.P. Morgan presentation?

Attendees include CEO Thomas J. Appio, EVP/CFO Jean-Jacques Charhon, and EVP/CMO & Head of R&D Jonathan Sadeh, M.D..

How can investors watch Bausch Health (BHC) at the J.P. Morgan Healthcare Conference on January 14, 2026?

Investors can access a live audio webcast at http://ir.bauschhealth.com/events-and-presentations and view a replay on the investor relations site after the event.

What time is Bausch Health's (BHC) webcast for the J.P. Morgan Healthcare Conference on January 14, 2026 in Eastern Time?

The webcast is scheduled for 6:45 p.m. Eastern Time on January 14, 2026.

Will Bausch Health (BHC) provide a replay of its J.P. Morgan Healthcare Conference presentation?

Yes. A replay will be available on Bausch Health's investor relations website following the event.

Where is the January 14, 2026 J.P. Morgan Healthcare Conference presentation by Bausch Health (BHC) being held?

The presentation is part of the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California.